gemcitabine has been researched along with n-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chen, XJ; Qu, X; Xiao, W; Zhou, SY | 1 |
1 other study(ies) available for gemcitabine and n-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide
Article | Year |
---|---|
NS-398 enhances the efficacy of gemcitabine against lung adenocarcinoma through up-regulation of p21WAF1 and p27KIP1 protein.
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Cell Line, Tumor; Cyclin-Dependent Kinase Inhibitor p21; Cyclin-Dependent Kinase Inhibitor p27; Cyclooxygenase 2 Inhibitors; Deoxycytidine; Drug Synergism; Gemcitabine; Humans; Lung Neoplasms; Nitrobenzenes; Sulfonamides; Up-Regulation | 2008 |